Another potentially game-changing discovery has come out of the lab of Feng Zhang ... In this recent work, Zhang’s team describes how the system—based on the Fanzor protein—uses RNA as ...

Feng Zhang, a biochemist at the Broad Institute ... the two pieces zip together and Fanzor can then cut the DNA. The team tested the Fanzor system in human cells but at first found that it was ...

The team discovered that Fanzor shares similarities with CRISPR in that it does ... ways that we can engineer them for use as molecular technologies.” Professor Feng Zhang was speaking to Molly ...

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company ...

Feng Zhang, Aera's founder and ... In starting another company, Zhang said he felt it was important to have a dedicated team focused on delivery. As with his other startups, Zhang is advising ...

Months before Feng Zhang met with a trio of investors ... human protein that could form virus-like structures, Zhang’s team began a fishing expedition through the human genome looking for ...

Akin Akinc was scouring his email spam box last summer, looking for a missing message, when he stumbled across an unexpected email from a quite recognizable name: Feng Zhang. Zhang, one of the ...

A new startup co-founded by CRISPR innovator Feng Zhang, a former executive at Grail and Illumina, and others has raised $57 million to develop a defanged form of gene editing that doesn’t cut ...

Chinese-American star scientist Zhang Feng made a rare public appearance in ... he said. Zhang and his team have also developed a delivery method for RNA-based gene therapies, which use components ...

A year later, in 2013, Feng Zhang and his colleagues at the Broad Institute of MIT and Harvard reported that they’d harnessed that system, known as Crispr, to edit human and animal cells in the lab.